Developing a novel Comorbidities Index for predicting 10-year mortality in Prostate Cancer patients: A computational data-driven approach
Researchers have developed a new computational framework to create a more accurate comorbidity index for prostate cancer patients eligible for radical prostatectomy. This data-driven approach uses Population-Based Bio-Inspired Algorithms to recalibrate comorbidity weights and optimize models for predicting ten-year survival. The new index, particularly when incorporating prostate cancer-specific variables, shows improved performance over existing indices like the Charlson Comorbidities Index, offering a more refined tool for patient selection and potentially avoiding overtreatment. AI
IMPACT Provides a more accurate tool for medical professionals to assess patient risk and guide treatment decisions.